Pictet Asset Management (UK)’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$17.6M Buy
101,312
+539
+0.5% +$93.8K 0.02% 549
2021
Q1
$20M Hold
100,773
0.02% 497
2020
Q4
$19.8M Buy
100,773
+55,335
+122% +$10.9M 0.03% 476
2020
Q3
$8.05M Buy
+45,438
New +$8.05M 0.01% 608